Therapeutic inhibition of miR-21 (e.g., antagomiRs/LNA) restores PTEN/PDCD4 signaling and suppresses growth in preclinical models, with supportive evidence in HNSCC (CAF transition) and other solid tumors [48]. Here, PDCD4 is linked to head and neck squamous cell carcinoma.